| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $335.6M | +17.3% |
| Cost of Revenue | $132.6M | +18.8% |
| R&D Expense | $28.2M | +38.4% |
| SG&A Expense | $71.8M | -9.8% |
| Operating Income | $32.5M | +139.5% |
| Interest Expense | $17.8M | +5.6% |
| Pre-tax Income | $18.8M | +655.7% |
| Income Tax | $4.0M | -59.3% |
| Net Income | $14.7M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $236.6M | +27.3% |
| Accounts Receivable | $72.2M | +20.1% |
| Current Assets | $342.3M | +24.6% |
| Total Assets | $1.57B | +4.0% |
| Current Liabilities | $103.2M | +11.9% |
| Long-term Debt | $293.0M | -0.6% |
| Total Liabilities | $493.3M | +5.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $92.5M | +53.2% |
| Capital Expenditures | $1.4M | +25.1% |
| Investing Cash Flow | -$27.8M | +89.7% |
| Financing Cash Flow | -$7.4M | -106.0% |
| Free Cash Flow | $91.1M | +53.8% |
| +211.0% |
| EPS (Basic) | $0.09 | +200.0% |
| EPS (Diluted) | $0.09 | +200.0% |
| Stockholders' Equity |
| $1.08B |
| +3.6% |